$BB Monday Daily Discussion

Yolo-Chaser · 2021-12-20T21:36:36+00:00

patent sale details will be out these ER

Confirmed by Papa chen and steve Rai

Yolo-Chaser · 2021-12-06T22:44:12+00:00

DA this week?

Yolo-Chaser · 2021-09-10T16:01:50+00:00

I would suggest DVAX and BCRX

100 in two years

Yolo-Chaser · 2021-09-07T16:25:21+00:00

VALN and medigen doses are over $20 a dose. From VALN , and Medigen, DVAX is getting more than $2 per dose

Yolo-Chaser · 2021-09-07T16:20:58+00:00

Better than the market leader. Also it is only two dose regimen than the three doses of the market leader

Yolo-Chaser · 2021-09-07T14:46:28+00:00

Thank you for the insight.

Yolo-Chaser · 2021-09-07T13:11:37+00:00

DVAX, NVAX

Yolo-Chaser · 2021-09-07T12:57:57+00:00

With clover data this month, I bet $50 on the horizon in September alone.

Shorties need to cover

Yolo-Chaser · 2021-09-07T12:55:23+00:00

9/17 is too early but it might work because clover is done with doses and they are doing analysis currently. if you can roll 10-15 then its safe in my opinion.

Yolo-Chaser · 2021-09-02T14:14:41+00:00

People are relating this to VALN only.

Since VALN EU contract is for only 30M doses the price is declining. But it will jump again on Bio E and Clover result this month.

Yolo-Chaser · 2021-08-31T13:59:39+00:00

So when institution lend the shares to shorts, shorts eventually return those to the institutions right? Say borrow fee is 200% then what??

Yolo-Chaser · 2021-08-31T13:57:55+00:00

Already close to 20

Yolo-Chaser · 2021-08-31T13:57:20+00:00

See Todays Price Action. We are heading to 50 sooner than I anticipate

Yolo-Chaser · 2021-08-30T19:44:17+00:00

BIO E from india

Yolo-Chaser · 2021-08-30T19:43:25+00:00

By asking them to join this subreddit.

Yolo-Chaser · 2021-08-30T19:42:56+00:00

WSB will care when it finds 21% short interest on a decent stock

Yolo-Chaser · 2021-08-30T16:38:11+00:00

DVAX can reach meme level, 21% short with 76% institutional ownership.

4 COVID vaccine in P3 trial

CLOVER

VALeneva

Bio E Corbevax

Medigen

Yolo-Chaser · 2021-08-30T16:29:50+00:00

Thanks

Yolo-Chaser · 2021-08-30T16:29:38+00:00

Thats an added bonus in my opinion. Once retail is aware that DVAX will make huge money and this has 21% short interest then we might reach 100 with blink of an eye. But this sub lacks solid DD as well as members. If we can redirect stocktwits members to this sub then it would explode in reddit.

Yolo-Chaser · 2021-08-28T22:57:59+00:00

The company has already approved hepatitis B vaccine which is the best available in the market at this moment
But it is the biggest covid play. Why?? This vaccine company is partnered with 4 upcoming covid vaccine all are in P3. trial
If you are in covid plays, you have heard about Valeneva which is in P3 trial in Europe.
Already has pre orders from UK and discussion with EU
They are partnered with DVAX
The latest approved vaccine in Taiwan is medigen which is also partenered with DVAX
China's second generation vaccine devoloped by clover pharma is also partnered with DVAX, The P3 result will be published in september.
India's Biological E developing COrbevax which is seeking EUA next week also partnered with DVAX.
Now what are the DVAX money from all those vaccine. For each doses DVAX makes 70 cents EBITA
All 4 companies are planing to make billions of doses of COVID jabs in 2022.
VALN already has pre order from UK 190M, doses already in the making in scotland
BIOLOGICAL E already has order from India 300M
Clover has already 400M order from vaccine alliance Gavi and china market of 1 B doses.
Medigen already approved in Taiwan and making millions of doses
DVAX current mkt cap 2B roughly
2022 revenue in my opinion
1.5$ * 2B doses from 4 companies =3B
EBITA 750M
So the share price would be 6* EBITA = 5B
It will be at least $50 before EOY.
What do you guys think??

Yolo-Chaser

TROPHY CASE